Atrial natriuretic peptide – cyclic GMP coupling and urinary sodium excretion during acute volume expansion in man
- 1 April 1990
- journal article
- research article
- Published by Canadian Science Publishing in Canadian Journal of Physiology and Pharmacology
- Vol. 68 (4) , 535-538
- https://doi.org/10.1139/y90-077
Abstract
The present study examines hormonal and renal responses to acute volume expansion in normal man, with particular emphasis on the atrial natriuretic peptide (ANP) – cyclic GMP coupling. Two liters of isotonic saline were infused into eight normotensive male subjects over a 1-h period. Plasma and urinary measurements were made before, during, and up to 300 min after the start of the saline infusion. With the initial increase in urinary sodium excretion there were increases in plasma ANP and plasma cyclic GMP, which reached maximum levels at 15 min after the end of the saline infusion. Urinary cyclic GMP increased gradually during saline infusion up to approximately 60 min after the end of the infusion. Plasma ANP and plasma and urinary cyclic GMP excretion gradually declined thereafter. By contrast, urinary sodium excretion remained elevated up to the end of the observation period. The saline infusion was associated with marked reductions in plasma renin activity and aldosterone, which persisted up to the end of the study. These results suggest a coupling between the increases in plasma ANP, the production of cyclic GMP, and urinary sodium excretion, in particular during the initial renal response to acute volume expansion. However, other mechanisms including the suppression of the rennin–angiotensin–aldosterone system may become increasingly important in the later natriuretic response to acute volume expansion.Key words: atrial natriuretic peptide, cyclic GMP, sodium, renal, human.This publication has 12 references indexed in Scilit:
- Contrasting plasma atrial natriuretic factor concentrations during comparable natriuresis with infusions of atrial natriuretic factor and saline in normal manClinical Science, 1988
- Direct vasodilatory action of atrial natriuretic factor on canine glomerular afferent arteriolesAmerican Journal of Physiology-Renal Physiology, 1988
- Role of atrial natriuretic factor, cyclic GMP and the renin–aldosterone system in acute volume regulation of healthy human subjectsEuropean Journal of Clinical Investigation, 1988
- Role of atrial natriuretic peptide and urinary cGMP in the natriuretic and diuretic response to central hypervolemia in normal human subjectsCanadian Journal of Physiology and Pharmacology, 1987
- Dissociation between plasma atrial natriuretic peptide levels and urinary sodium excretion after intravenous saline infusion in normal manClinical Science, 1987
- Cardiorenal-endocrine dynamics during and following volume expansionAmerican Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 1987
- High Plasma Concentrations of Human Atrial Natriuretic Polypeptide in Aged Men*Journal of Clinical Endocrinology & Metabolism, 1987
- In vivo evidence that cGMP is the second messenger for atrial natriuretic factor.Proceedings of the National Academy of Sciences, 1986
- Concomitant increase in plasma atrial natriuretic peptide and cyclic GMP during volume loadingJournal of Molecular Medicine, 1985
- RAPID INCREASE IN PLASMA AND URINARY CYCLIC GMP AFTER BOLUS INJECTION OF ATRIAL NATRIURETIC FACTOR IN MANJournal of Clinical Endocrinology & Metabolism, 1985